STOCK TITAN

Ontrak, Inc. Announces Reverse Stock Split

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)

Ontrak Inc (NASDAQ: OTRK) announced a 1-for-15 reverse stock split effective September 23, 2024. This move aims to increase the bid price of common stock to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The stock will continue trading under the symbol 'OTRK' with a new CUSIP number. The split will reduce outstanding shares from approximately 48.0 million to 3.2 million. No fractional shares will be issued; fractional interests will be rounded up to the next whole share. The split will not change stockholders' ownership percentages or voting power, except for minor adjustments due to fractional share treatment. Proportionate adjustments will be made to stock options, incentive plans, and warrants.

Ontrak Inc (NASDAQ: OTRK) ha annunciato un raggruppamento di azioni 1 a 15 efficace dal 23 settembre 2024. Questa mossa mira ad aumentare il prezzo di offerta delle azioni ordinarie per ristabilire la conformità con il requisito di prezzo minimo di $1,00 imposto dal Nasdaq. Le azioni continueranno a essere negoziate con il simbolo 'OTRK' e avranno un nuovo numero CUSIP. Il raggruppamento ridurrà le azioni in circolazione da circa 48,0 milioni a 3,2 milioni. Non verranno emesse azioni frazionarie; le quote frazionarie saranno arrotondate all'azione intera successiva. Il raggruppamento non modificherà le percentuali di proprietà degli azionisti o il potere di voto, ad eccezione di lievi aggiustamenti dovuti al trattamento delle azioni frazionarie. Verranno effettuati aggiustamenti proporzionali alle opzioni su azioni, ai piani incentivanti e ai warrant.

Ontrak Inc (NASDAQ: OTRK) anunció un split inverso de acciones 1 por 15 que será efectivo el 23 de septiembre de 2024. Este movimiento tiene como objetivo aumentar el precio de la oferta de las acciones comunes para volver a cumplir con el requisito de precio mínimo de $1.00 establecido por Nasdaq. Las acciones seguirán cotizando bajo el símbolo 'OTRK' con un nuevo número CUSIP. El split reducirá las acciones en circulación de aproximadamente 48.0 millones a 3.2 millones. No se emitirán acciones fraccionarias; los intereses fraccionarios se redondearán a la siguiente acción entera. El split no cambiará los porcentajes de propiedad o el poder de voto de los accionistas, excepto por ajustes menores debido al tratamiento de acciones fraccionarias. Se realizarán ajustes proporcionales a las opciones sobre acciones, planes de incentivos y warrants.

온트락 주식회사 (NASDAQ: OTRK)는 2024년 9월 23일부터 1대 15의 역주식 분할을 시행한다고 발표했습니다. 이번 조치는 주식의 입찰 가격을 높여 나스닥의 최소 입찰 가격 요건인 $1.00을 다시 충족하기 위한 것입니다. 주식은 'OTRK' 기호로 계속 거래되며 새로운 CUSIP 번호가 부여됩니다. 이 분할로 인해 유통 주식 수는 약 4800만 주에서 320만 주로 줄어듭니다. 부분 주식은 발행되지 않습니다; 부분 주식은 다음 전체 주식으로 올림 처리됩니다. 분할은 주주들의 소유 비율이나 투표 권한을 변경하지 않으며, 부분 주식 처리로 인한 미세 조정이 있을 수 있습니다. 주식 옵션, 인센티브 플랜 및 워런트에 대해 비례적인 조정이 이루어질 것입니다.

Ontrak Inc (NASDAQ: OTRK) a annoncé un fractionnement inversé d'actions de 1 pour 15 effectif le 23 septembre 2024. Cette mesure vise à augmenter le prix de l'offre des actions ordinaires pour retrouver la conformité avec l'exigence de prix d'offre minimum de 1,00 $ du Nasdaq. Les actions continueront d'être négociées sous le symbole 'OTRK' avec un nouveau numéro CUSIP. Le fractionnement réduira le nombre d'actions en circulation d'environ 48,0 millions à 3,2 millions. Aucune action fractionnaire ne sera émise ; les intérêts fractionnaires seront arrondis à l'action entière suivante. Le fractionnement ne changera pas les pourcentages de propriété des actionnaires ni leur pouvoir de vote, sauf pour de légers ajustements dus au traitement des actions fractionnaires. Des ajustements proportionnels seront effectués sur les options d'actions, les plans d'incitation et les bons de souscription.

Ontrak Inc (NASDAQ: OTRK) gab einen 1-für-15 Reverse Stock Split bekannt, der am 23. September 2024 wirksam wird. Diese Maßnahme zielt darauf ab, den Angebotspreis der Stammaktien zu erhöhen, um die Anforderungen des Nasdaq von mindestens $1,00 wieder zu erfüllen. Die Aktien werden weiterhin unter dem Symbol 'OTRK' gehandelt und erhalten eine neue CUSIP-Nummer. Der Split reduziert die ausgegebenen Aktien von etwa 48,0 Millionen auf 3,2 Millionen. Es werden keine Bruchstücke von Aktien ausgegeben; Bruchteile werden auf die nächste ganze Aktie aufgerundet. Der Split ändert nicht die Eigentumsanteile oder Stimmrechte der Aktionäre, abgesehen von geringfügigen Anpassungen aufgrund der Behandlung von Bruchstücken. Verhältnismäßige Anpassungen werden bei Aktienoptionen, Anreizplänen und Warrants vorgenommen.

Positive
  • Potential to regain compliance with Nasdaq's $1.00 minimum bid price requirement
  • Maintains listing on Nasdaq Capital Market
  • No change in stockholders' percentage ownership or voting power (except for minor fractional adjustments)
Negative
  • Significant reduction in total outstanding shares (from 48.0 million to 3.2 million)
  • Potential market perception issues associated with reverse stock splits
  • Indicates underlying financial or market performance concerns necessitating the split

This reverse stock split is a strategic move by Ontrak to maintain its Nasdaq listing. While it doesn't change the company's fundamental value, it could have significant implications:

  • The 1-for-15 split will reduce outstanding shares from 48 million to 3.2 million, potentially increasing the stock's perceived value.
  • It's aimed at boosting the stock price above $1 to meet Nasdaq's minimum bid requirement, which is important for maintaining investor confidence and access to capital markets.
  • However, reverse splits often signal financial distress and can lead to increased scrutiny from investors. The company needs to demonstrate improved financial performance to sustain any price increase.

Investors should monitor post-split trading patterns and any changes in institutional ownership, as these could indicate market sentiment towards Ontrak's future prospects.

Ontrak's reverse stock split reflects broader challenges in the AI-powered healthcare sector:

  • The move suggests Ontrak is struggling to maintain investor interest, possibly due to fierce competition or slow adoption of its AI-driven behavioral health solutions.
  • The healthcare AI market is expected to grow at a CAGR of 37% through 2030, but Ontrak's need for this split indicates it may not be capturing this growth effectively.
  • Post-split, the reduced float could lead to increased volatility, which might attract short-term traders but deter long-term investors seeking stability.

This split doesn't address underlying business challenges. Ontrak needs to demonstrate improved market penetration and financial performance to regain investor confidence in this high-potential but competitive sector.

Shares Expected to Begin Trading on Split-Adjusted Basis on September 23, 2024

MIAMI--(BUSINESS WIRE)-- Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, today announced that it will implement a 1-for-15 reverse split of the issued shares of its common stock, effective at 12:01 a.m. Eastern Time on September 23, 2024. The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on September 23, 2024, and will continue to trade on The Nasdaq Capital Market under the symbol “OTRK.” The new CUSIP number for the common stock will be 683373 401.

The reverse stock split is intended to increase the bid price of the common stock to enable the Company to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The Company’s stockholders authorized the reverse stock split at the Company’s annual meeting of stockholders held on September 10, 2024.

When the reverse stock split becomes effective, every 15 shares of the Company’s common stock issued and outstanding or held by the Company in treasury will automatically be combined and reclassified into one share of common stock. No fractional shares will be issued as a result of the reverse stock split. Stockholders who would otherwise be entitled to receive a fractional share will instead automatically have their fractional interests rounded up to the next whole share, after aggregating all the fractional interests of a holder resulting from the reverse stock split. The reverse stock split will affect all stockholders uniformly and will not change any stockholder’s percentage ownership interest or any stockholder’s proportionate voting power, except for immaterial changes that may result from the treatment of fractional shares. The reverse stock split will not change the number of authorized shares of the Company’s common stock or the par value per share of the Company’s common stock.

The reverse stock split will reduce the number of issued and outstanding shares of the Company’s common stock from approximately 48.0 million to approximately 3.2 million.

As a result of the reverse stock split, proportionate adjustments will be made to the per share exercise prices of, and the number of shares underlying, the Company’s outstanding stock options, as well as to the number of shares available for future awards granted under the Company’s stock incentive plans. In addition, proportionate adjustments will be made to the per share exercise prices of, and the number of shares underlying, outstanding warrants to purchase shares of the Company’s common stock.

The combination of, and reduction in, the issued shares of common stock as a result of the reverse stock split will occur automatically at the effective time of the reverse stock split without any additional action on the part of the Company’s stockholders. The Company's transfer agent, Equiniti Trust Company, LLC, is acting as the exchange agent for the reverse stock split and will send stockholders of record holding their shares electronically in book-entry form a transaction notice indicating the number of shares of common stock held after the reverse stock split. Stockholders who hold their shares through a broker, bank, or other nominee will have their positions adjusted to reflect the reverse stock split, subject to their broker, bank, or other nominee’s particular processes, and are not expected to be required to take any action in connection with the reverse stock split.

Additional information regarding the reverse stock split can be found in the Company’s definitive proxy statement for the annual meeting of stockholders of the Company held on September 10, 2024, which was filed with the U.S. Securities and Exchange Commission on July 29, 2024, a copy of which is available at www.sec.gov and on the Company's website.

About Ontrak

Ontrak Health (Nasdaq: OTRK) is a leading AI and technology-enabled behavioral healthcare company whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder, and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socioeconomic, medical, and health system barriers that exacerbate the severity of their comorbid illnesses. The company's integrated intervention platform uses AI, predictive analytics, and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.

Forward-Looking Statements

The Company cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “contemplate,” “project,” “target,” “objective,” or the negative version of these words and similar expressions. In this press release, forward-looking statements include, but are not limited to, statements relating to the timing, completion and effect of the reverse stock split and the Company’s ability to regain compliance with Nasdaq’s minimum bid price requirement and continue to have its common stock listed on The Nasdaq Capital Market. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, without limitation, the risk that Nasdaq may not process the reverse stock split on the expected timeline; the risk that after the reverse stock split the closing bid price of the Company’s common stock is not at least $1.00 per share for a minimum of ten consecutive trading sessions; the potential for Nasdaq to suspend trading in or to delist the Company’s common stock. Forward-looking statements are based upon the Company’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. For a detailed description of risks and uncertainties the Company faces, you are encouraged to review the documents the Company files with the SEC including the Company’s recent filings on Form 8-K, Form 10-K and Form 10-Q. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Company Contact:

Brandon LaVerne

Chief Executive Officer

blaverne@ontrakhealth.com

Investor Relations:

Ryan Halsted

Gilmartin Group

investors@ontrakhealth.com

Source: Ontrak, Inc.

FAQ

When will Ontrak's (OTRK) reverse stock split take effect?

Ontrak's 1-for-15 reverse stock split will take effect at 12:01 a.m. Eastern Time on September 23, 2024. The stock is expected to begin trading on a split-adjusted basis when the market opens on the same day.

What is the purpose of Ontrak's (OTRK) reverse stock split?

The primary purpose of Ontrak's reverse stock split is to increase the bid price of its common stock to regain compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.

How will Ontrak's (OTRK) reverse stock split affect the number of outstanding shares?

Ontrak's reverse stock split will reduce the number of issued and outstanding shares from approximately 48.0 million to approximately 3.2 million.

Will Ontrak's (OTRK) stock symbol change after the reverse split?

No, Ontrak's stock will continue to trade on The Nasdaq Capital Market under the symbol 'OTRK' after the reverse split. However, it will have a new CUSIP number: 683373 401.

Ontrak, Inc.

NASDAQ:OTRK

OTRK Rankings

OTRK Latest News

OTRK Stock Data

9.99M
47.97M
60.63%
0.56%
0.54%
Health Information Services
Services-misc Health & Allied Services, Nec
Link
United States of America
MIAMI